BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37250921)

  • 41. Novel target and treatment agents for natural killer/T-cell lymphoma.
    Tian XP; Cao Y; Cai J; Zhang YC; Zou QH; Wang JN; Fang Y; Wang JH; Guo SB; Cai QQ
    J Hematol Oncol; 2023 Jul; 16(1):78. PubMed ID: 37480137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
    Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
    Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
    Ando S; Kawada JI; Watanabe T; Suzuki M; Sato Y; Torii Y; Asai M; Goshima F; Murata T; Shimizu N; Ito Y; Kimura H
    Oncotarget; 2016 Nov; 7(47):76793-76805. PubMed ID: 27732937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.
    Kim WY; Nam SJ; Kim S; Kim TM; Heo DS; Kim CW; Jeon YK
    Leuk Lymphoma; 2015 Jun; 56(6):1778-86. PubMed ID: 25288491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extranodal NK/T-cell lymphoma primarily presenting as two adjacent slowly growing skin nodules with prominent epidermotropism and CD30 expression, a case report and review of literature.
    Mohammed A; Dave U; Ms SR; Alomari AK
    Dermatol Online J; 2021 Dec; 27(12):. PubMed ID: 35499432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case report.
    Lai J; Xu P; Jiang X; Zhou S; Liu A
    BMC Cancer; 2017 Jul; 17(1):507. PubMed ID: 28754096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma.
    Zhang X; Ji W; Huang R; Li L; Wang X; Li L; Fu X; Sun Z; Li Z; Chen Q; Zhang M
    Oncotarget; 2016 Aug; 7(33):53808-53819. PubMed ID: 27462776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute Epstein-Barr virus-positive cytotoxic T cell lymphoid hyperplasia in the upper aerodigestive tract, mimicking extranodal natural killer/T cell lymphoma, nasal type.
    Jianlan X; Yuhua H; Yuanyuan Z; Yanlin Z; Ping W; Wei L; Xiaoge Z; Mulan J
    Virchows Arch; 2019 Feb; 474(2):219-226. PubMed ID: 30488123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A nuclear NKRF interacting long noncoding RNA controls EBV eradication and suppresses tumor progression in natural killer/T-cell lymphoma.
    Wang WF; Zhong HJ; Cheng S; Fu D; Zhao Y; Cai HM; Xiong J; Zhao WL
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166722. PubMed ID: 37084822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.
    Iwata S; Saito T; Ito Y; Kamakura M; Gotoh K; Kawada J; Nishiyama Y; Kimura H
    Cancer Sci; 2012 Feb; 103(2):375-81. PubMed ID: 22017376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
    Chen Z; Huang H; Hong H; Huang H; Weng H; Yu L; Xiao J; Wang Z; Fang X; Yao Y; Yue JX; Lin T
    Genome Med; 2024 Apr; 16(1):48. PubMed ID: 38566223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and clinical significance of neuropilin-1 in Epstein-Barr virus-associated lymphomas.
    Gu YY; Luo B; Li CY; Huang LS; Chen G; Feng ZB; Peng ZG
    Cancer Biomark; 2019; 25(3):259-273. PubMed ID: 31282408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.
    Xiong J; Dai YT; Wang WF; Zhang H; Wang CF; Yin T; Cheng S; Zhong HJ; Yu SH; Jiang L; Wang SY; Fang H; Zhang RH; Zhu Y; Yi HM; Jiang XF; Chen JY; Wang L; Xu PP; Chen SJ; Zhao WL
    Sci Bull (Beijing); 2023 Nov; 68(21):2607-2619. PubMed ID: 37798178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma.
    Qi F; Wei Y; Wu M; Sun Y; Xie Y; Lin N; Liu W; Wang W; Song Y; Zhu J
    Ann Hematol; 2024 May; 103(5):1643-1653. PubMed ID: 38191717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
    Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
    Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38
    Lin R; Li X; Wu S; Qian S; Hou H; Dong M; Zhang X; Zhang M
    Exp Cell Res; 2021 Oct; 407(1):112790. PubMed ID: 34418460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in multiple omics of natural-killer/T cell lymphoma.
    Xiong J; Zhao WL
    J Hematol Oncol; 2018 Dec; 11(1):134. PubMed ID: 30514323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and significance of Ku80 and PDGFR-α in nasal NK/T-cell lymphoma.
    Li J; Chen P; Liu W; Xia Z; Shi F; Zhong M
    Pathol Res Pract; 2016 Mar; 212(3):204-9. PubMed ID: 26778387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.